PCM
MSOS icon

Prelude Capital Management’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Prelude Capital Management’s Portfolio MSOS Stock Details MSOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-98,800
Closed -$691K – 1355
2022
Q4 		$691K Buy
98,800
+85,400
+637% +$879K 0.04% 463
2022
Q3 		$55K Sell
13,400
-900
-6% -$10.4K ﹤0.01% 1224
2022
Q2 		$148K Sell
14,300
-400
-3% -$5.94K ﹤0.01% 1354
2022
Q1 		$307K Sell
14,700
-4,500
-23% -$98.2K 0.01% 1067
2021
Q4 		$491K Buy
+19,200
New +$530K 0.01% 1028

Other funds holding MSOS

AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
IECM
Intrinsic Edge Capital Management Chicago, Illinois $967M AUM 94.27% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return

Prelude Capital Management's MSOS Position: Q1 2026 in Review

Prelude Capital Management sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q1 2026, closing a stake of 93,668 shares — an estimated $442K sold.

Prelude Capital Management first reported a position in MSOS in Q2 2021 and held it in 8 quarters. The position peaked at $1.45M in Q1 2022. 168 funds tracked by Wall St. Rank hold MSOS as of Q1 2026.

  • Prelude Capital Management reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q1 2026 after selling out during the quarter.
  • Prelude Capital Management sold 93,668 AdvisorShares Pure US Cannabis ETF shares in Q1 2026, an estimated $442K.
  • Prelude Capital Management first reported a position in AdvisorShares Pure US Cannabis ETF in Q2 2021 and held it in 8 quarters.
  • Prelude Capital Management's AdvisorShares Pure US Cannabis ETF position peaked at $1.45M in Q1 2022.
  • 168 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.